INTRODUCTION
============

Pigs are a useful experimental animal for biomedical research because of their anatomical and physiological similarities with humans ([@b19-ajas-27-3-324-4]) and relatively high production efficiency ([@b14-ajas-27-3-324-4]). For these reasons, various transgenic pigs have been generated since the middle of the 1980s ([@b23-ajas-27-3-324-4]). However, production of knockout or gene targeted pigs was extremely rare until very recently because of very low efficiency of homologous recombination in somatic cells and a lack of appropriate technologies, such as embryonic stem cells, in this species. Lately, pioneering work using zinc finger nucleases (ZFNs) to produce knockout rats ([@b7-ajas-27-3-324-4]) enabled us to perform a new approach for producing knockout mammals without homologous recombination or embryonic stem cells. ZFNs are engineered proteins composed of the FokI endonuclease domain linked to a DNA-binding zinc finger protein domain. Pairs of the ZFNs efficiently generate sequence-specific DNA double-strand breaks on a chromosome; consequently, targeted mutations can be introduced into cells of interest ([@b12-ajas-27-3-324-4]; [@b11-ajas-27-3-324-4]). Since [@b22-ajas-27-3-324-4] first showed that the ZFN system can be used in porcine cells, several knockout pigs have been generated using ZFNs and somatic cell nuclear transfer (SCNT) techniques.

However, the protocols developed in the previous studies cannot be used as a general application for producing knockout pigs with ZFNs. Most of the previous reports screened for the presence of ZFN-mediated mutations in donor cells by detecting loss of a specific surface molecule ([@b9-ajas-27-3-324-4]; [@b15-ajas-27-3-324-4]; [@b16-ajas-27-3-324-4]) or ectopic marker gene expression ([@b24-ajas-27-3-324-4]) affected by the mutation. For example, a specific surface molecule, alpha 1,3-galactose, is only available to detect mutations of alpha 1,3 galactosyltransferase and related genes. Also, ectopic marker gene expression, such as eGFP or luciferase, is necessary to generate the cell lines which have the gene sequences prior to gene targeting. Unfortunately, most of the other mutant cells generated by ZFN or other engineered nucleases, especially endogenous gene-modified cells, are somewhat phenotypically indistinguishable. Therefore, alternative protocols for screening or enriching mutated cells are needed.

To overcome the hurdle, we developed a new protocol for generating mutated porcine embryos using a transiently transfected episomal reporter-based enrichment system for cells with ZFN-induced mutations ([@b11-ajas-27-3-324-4]; [@b10-ajas-27-3-324-4]). With the enrichment system, mutation frequencies of 8.7% to 47% (11- to 17-fold higher than frequencies in non-enriched cell populations) can be achieved. Moreover, gene-modified cells enriched with this system are alive and suitable for subsequent experiments. Hence, we assumed that this enrichment system, in combination with the SCNT technique, could provide a new generalized platform for producing mutated embryos. In the present study, we assessed the enrichment system in porcine cells and analyzed mutations in cloned pig embryos derived from the enriched ZFN-treated cells.

MATERIALS AND METHODS
=====================

ZFNs and surrogate reporters
----------------------------

Plasmids encoding ZFNs that target exon 6 of the pig CMP-N-acetylneuraminic acid hydroxylase (CMAH) gene were previously described ([@b12-ajas-27-3-324-4]). Enrichment system with reporters, eGFP or H-2K^k^ as selection markers for fluorescence activated cell sorting (FACS) and magnetic activated cell sorting (MACS), respectively were constructed as previously described ([@b11-ajas-27-3-324-4]; [@b10-ajas-27-3-324-4]).

Preparation of cells and culture conditions
-------------------------------------------

A primary culture of pig fetal fibroblast cells that has been established as described by [@b4-ajas-27-3-324-4] was used. Briefly, fetal tissues were minced and dissociated in TrypLE Express (Gibco, CA, USA) for 10 min at 37°C. Cells were cultured in Dulbecco's modified Eagle's/Nutrient Mixture F-12 medium (DMEM/F12, Gibco) supplemented with 10% (v/v) fetal bovine serum, 1 mM Glutamax I (Gibco), 25 mM NaHCO~3~, 1% (v/v) minimal essential medium, nonessential amino acid solution (Gibco) and 1% (v/v) Anti-Anti (Gibco) at 39°C in a humidified atmosphere of 5% CO~2~ and 95% air.

Plasmid DNAs transfection
-------------------------

Fibroblasts were cultured to 80% to 90% confluence, then washed twice with D-PBS(−) (Gibco) and treated with 0.05% trypsin-EDTA (Gibco) to isolate and collect. Fibroblasts (2×10^6^ cells) were electroporated using a 100 μL Nucleocuvette, CA137 program code, in an Amaxa 4D-Nucleofector (Lonza, P3 Primary Cell 4D-Nucleofector X Kit L) with a total of 45 μg plasmid DNA at a 2:2:1 weight ratio (plasmid encoding a left ZFN: plasmid encoding a right ZFN: eGFP reporter or H-2K^k^ reporter). Mutant cells were enriched using a flow cytometer (FACSAria III, BD Biosciences, USA) or MACSelect K^k^ System (Miltenyi Biotec, Bergisch Gladbach, Germany) as described ([@b11-ajas-27-3-324-4]; [@b10-ajas-27-3-324-4]). The sorted cells were cultured for 2 additional days after sorting prior to SCNT or mutation analysis for proliferation and removing the dead cells.

Analysis of mutations
---------------------

For detection of ZFN-induced mutations at the pig CMAH locus, the ZFN target locus was amplified from genomic DNA isolated from fibroblasts or cloned blastocysts (DNeasy kit, Qiagen) by nested PCR and subjected to the T7E1 assay ([@b12-ajas-27-3-324-4]). Primers used for the amplifications of the CMAH locus were as follows: 1st PCR/5′-tgtggacgtgccagactat-3′ and 5′-aaggcaatcaggctccttag-3′, 2nd PCR/5′-tctacggaaatgctcctgct-3′ and 5′-tctacggaaatgctcctgct-3′.

For sequence analysis, PCR amplicons that included ZFN-target sites were purified using the Gel Extraction Kit (MACHERRY-ALGEN) and cloned into the T-Blunt vector using the T-Blunt PCR Cloning Kit (SolGent). Cloned plasmids were sequenced using the primers used for PCR amplification.

Production and culture of cloned porcine embryos
------------------------------------------------

*In vitro* maturation of porcine oocytes, SCNT, and *in vitro* culture of the cloned embryos were performed as described elsewhere ([@b17-ajas-27-3-324-4]) with slight modification. Briefly, ovaries were collected at a local abattoir and transported to the laboratory in sterile physical saline at 30°C to 35°C. Cumulus-oocyte complexes (COCs) were aspirated from antral follicles (3 to 6 mm) with 18-gauge needle attached to a 10 mL disposable syringe. COCs with several layers of cumulus cells and uniform cytoplasm were chosen and cultured in tissue culture medium 199 (Gibco) supplemented with 10 ng/mL EGF, 0.57 mM cysteine, 0.91 mM sodium pyruvate, 5 μg/mL insulin, 1% (v/v) Pen-Strep (Gibco) and 10% porcine follicular fluid at 39°C in a humidified atmosphere of 5% CO~2~. For first 22 h of culture, 0.5 μg/mL follicle stimulating hormone and 0.5 μg/mL luteinizing hormone were added to the culture medium and then removed for a further 22 h. After a total of 44 h maturation culture, oocytes were denuded by pipetting with 0.1% hyaluronidase in TALP medium supplemented with 0.1% polyvinyl alcohol. Denuded oocytes with evenly-granulated and homogeneous cytoplasm were selected and then utilized for SCNT. A cumulus-free oocyte was held with a holding micropipette and the zona pellucida was partially dissected with a fine glass needle to make a slit near the adjacent cytoplasm, presumably containing the metaphase-II chromosomes, were extruded by aspiration with the same needle. Enucleation was confirmed by staining the cytoplasm with 0.5 μg/mL bisbenzimide during manipulation. ZFN-treated and sorted cells were trypsinized and observed under a microscope (Nikon). Cells with impaired membrane were excluded as morphological changes in cell membrane like irregular cell surface indicate cell death ([@b1-ajas-27-3-324-4]; [@b21-ajas-27-3-324-4]). The cells expressed both RFP and eGFP ([Figure 2a](#f2-ajas-27-3-324-4){ref-type="fig"}, circled) were manually selected using a micromanipulator (Nikon-Narishige, Japan) and fused with enucleated porcine oocytes ([Figure 2b](#f2-ajas-27-3-324-4){ref-type="fig"}) with an electro cell fusion generator (LF101, Nepagene, Ichikawa, Japan) by applying a single direct current pulse (200 V/mm, 20 μs) and a pre- and post-pulse alterating current field of 5 V, 1 MHz, for 5 s, respectively. After 0.5 to 1.5 h oocytes were activated with a single DC pulse of 1.5 kV/cm for 60 μs utilizing BTX electro-cell Manipulator 2001 (BTX, Inc., San Diego, USA). Reconstructed embryos were cultured in porcine zygote medium-5 (Funakoshi, IFP0410P, Tokyo, Japan) was maintained under a humidified atmosphere of 5% CO~2~, 5% O~2~, and 90% N~2~ at 38.5°C for 7 days; cleavage and blastocyst rates were recorded at day 2 and 7, respectively.

Statistical analysis
--------------------

One way ANOVA analysis was performed to compare cleavages and blastocysts rates between each group after SCNT using Prism software (Version 6, GraphPad).

RESULTS AND DISCUSSION
======================

Unlike in rodents, it is technically and economically difficult to obtain *in vivo* fertilized porcine embryos for genetic manipulation. Moreover, the high incidence of polyspermy ([@b8-ajas-27-3-324-4]) and low cryo-survival of boar sperm (Rodriguez-Martinez and Wallgren, 2010) also create problems for the production of *in vitro* fertilized embryos in this species. Therefore, microinjection of ZFNs into fertilized embryos, a technique used for producing knockout rodents, cannot easily be translated to pigs in most laboratories. On that account, we modified our SCNT protocols to produce mutated pig embryos. In first, mutated cells were prepared by transfection of ZFNs into porcine fibroblasts, coupled with reporter-based enrichment systems utilizing two different cell sorting methods, FACS and MACS, described previously ([@b11-ajas-27-3-324-4]; [@b10-ajas-27-3-324-4]). The enriched mutated cells were used as donor cells for SCNT. During the SCNT procedure, we re-confirmed the expression of reporter genes under microscope and only the cells with double positive for RFP and eGFP expressions ([Figure 2a](#f2-ajas-27-3-324-4){ref-type="fig"}, circled) were used to produce cloned embryos.

To test the feasibility of using these knockout cell enrichment approaches for pig fibroblast cells, we used ZFNs targeting CMAH exon 6 ([Figure 1a](#f1-ajas-27-3-324-4){ref-type="fig"}) and surrogate reporters containing either the eGFP gene alone (eGFP reporter) or eGFP and a truncated H-2K^k^ surface marker (MACS reporter), whose expression in cells can be recovered by a ZFN-induced frameshift mutation in CMAH. Indeed, the use of both surrogate reporter systems together with appropriate sorting methods (FACS or MACS) successfully supported enrichment of fibroblasts containing ZFN-induced mutations in CMAH ([Figure 1c and d](#f1-ajas-27-3-324-4){ref-type="fig"}). When these mutant-enriched cell populations were subjected to SCNT, the competence of reconstructed embryos derived from the MACS-separated and FACS-separated cell populations was comparable. Importantly, whereas the cloned embryos from the MACS-separated cell population showed a similar rate of blastocyst development as compared to the control, the blastocyst development of the cloned embryos from the FACS-separated cell population was significantly impaired ([Table 1](#t1-ajas-27-3-324-4){ref-type="table"}; 13.1±2.5% vs 24.3± 0.8%). This difference might be caused by various stresses --- including hydraulic pressure, shear force, vibrations, and high voltages --- that cells experience during flow cytometry ([@b25-ajas-27-3-324-4]). Consistent with this idea, large numbers of membrane-damaged cells were observed after FACS-mediated cell separation.

We also analyzed the ZFN target sites in the cloned blastocysts. The T7e1 assay results revealed that ZFN-induced mutations at the target site in embryos from both the FACS and MACS groups ([Figure 3a](#f3-ajas-27-3-324-4){ref-type="fig"}). Mutated sequences, including insertions, deletions, and substitutions at the target site, as well as the wild-type sequence, were found in the assessed blastocysts ([Figure 3b](#f3-ajas-27-3-324-4){ref-type="fig"}). Therefore, the mutations established in the study might not be biallelic. Interestingly, three different types of sequences were detected in the FACS group. This result revealed that the ZFN-initiated double-strand breaks and repair by the non-homologous end joining pathways might be still ongoing after the one-cell embryo stage. This phenomenon has been commonly observed in various species of animals derived from ZFN-treated embryos, such as zebrafish ([@b5-ajas-27-3-324-4]), mouse ([@b2-ajas-27-3-324-4]), rabbit ([@b6-ajas-27-3-324-4]), and rat ([@b7-ajas-27-3-324-4]). Recently, mutant mice with biallelic deletions of the target site were obtained by injection of transcription activator-like effector nucleases (TALENs), another type of artificial restriction enzyme, into 1-cell embryos ([@b20-ajas-27-3-324-4]). Thus, the use of TALENs instead of ZFNs might facilitate the establishment of homozygous mutations in pig embryos. Our reporter based enrichment system also can be used with TALENs, therefore, it can be recommended to modify the current method for using TALENs instead of ZFNs to produce biallelic mutated pigs.

Recent reports showed that knockout pigs could be produced by co-transfection of nucleases (ZFNs or TALENs) with an antibiotic-selection marker followed by clonal selection ([@b26-ajas-27-3-324-4]; [@b3-ajas-27-3-324-4]). These previous reports suggested a novel approach for generating knockout pigs. However, clonal selection from a single primary cell requires a lengthy period of time and sophisticated techniques. Use of the reporter-based enrichment system represents an alternative to the antibiotic-based selection method for reducing the time and effort needed to produce knockout pigs.

In conclusion, our results show that porcine transgenesis can be accomplished using ZFNs together with an enrichment reporter system. We described two types of transient reporter enrichment systems that can enrich cells with nuclease-induced mutation using FACS or MACS. The cloned embryos derived from cells enriched using MACS showed better developmental competence than did those derived from cells enriched by FACS. The desired mutated sequence was found in both systems. Therefore, the current procedure could provide a new generalized platform for producing mutated porcine embryos.
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![Enrichment system for cells containing ZFN-mediated mutations. (a) Sequences of the ZFN binding sites in the CMAH gene. The binding site of the right (red letters) and left (blue letters) ZFNs and the spacer sequence (underlined) are indicated. (b) The zinc finger module composition of CMAH ZFNs. (c and d) ZFN-driven CMAH mutations detected by the T7E1 assay in cell populations isolated by FACS (c) and MACS (d) using a ZFN surrogate reporter. H-2K^k^, a truncated mouse MHC class I, is used a selection marker for MACS. Arrows indicate the expected positions of DNA bands from specific cleavage of a mutated site by the mismatch-sensitive T7E1 enzyme. The numbers at the bottom of the gel indicate mutation percentages calculated by band intensities.](ajas-27-3-324-4f1){#f1-ajas-27-3-324-4}

![Somatic cell nuclear transfer with ZFN-treated donor cells. (a) Cells with intact membrane (circled in red) expressing both eGFP and RFP simultaneously (circled in white) were selected as donor cells (scale bar = 200 μm). (b) A manually-selected donor cell (arrow) was fused with a porcine oocyte matured *in vitro* (scale bar = 100 μm).](ajas-27-3-324-4f2){#f2-ajas-27-3-324-4}

![Mutations in cloned blastocysts derived from ZFN-treated cells. (a) The T7e1 assay showed ZFN-mediated mutations in cloned blastocysts. (b) Genomic DNA sequences from the cloned blastocyst.](ajas-27-3-324-4f3){#f3-ajas-27-3-324-4}

###### 

*In vitro* culture of cloned embryos derived from ZFN-treated donor cells

            n     Cleavage (%)      Blastocyst (%)
  --------- ----- ----------------- ---------------------------------------------------------------
  Control   105   82 (77.7±4.5)     20 (24.3±0.8)[a](#tfn1-ajas-27-3-324-4){ref-type="table-fn"}
  FACS      157   116 (61.11±6.5)   16 (13.1±2.5)[b](#tfn1-ajas-27-3-324-4){ref-type="table-fn"}
  MACS      119   83 (65.0±1.9)     14 (16.7±1.6)[ab](#tfn1-ajas-27-3-324-4){ref-type="table-fn"}

Values with different superscript letters in the same column indicate significant differences.
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